AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $262,000 | -45.2% | 34,838 | -26.9% | 0.01% | -40.0% |
| Q2 2022 | $478,000 | -16.7% | 47,638 | +2.8% | 0.02% | -4.8% |
| Q1 2022 | $574,000 | -84.0% | 46,338 | -70.4% | 0.02% | -83.5% |
| Q4 2021 | $3,578,000 | -27.0% | 156,458 | -29.4% | 0.13% | -39.2% |
| Q3 2021 | $4,904,000 | +272.9% | 221,633 | +118.5% | 0.21% | +287.0% |
| Q2 2021 | $1,315,000 | -7.5% | 101,433 | -7.3% | 0.05% | -8.5% |
| Q1 2021 | $1,422,000 | -35.5% | 109,420 | -31.4% | 0.06% | -30.6% |
| Q4 2020 | $2,205,000 | -8.8% | 159,441 | -2.8% | 0.08% | -26.1% |
| Q3 2020 | $2,417,000 | +3.3% | 164,108 | +14.0% | 0.12% | -12.9% |
| Q2 2020 | $2,340,000 | +218.4% | 143,958 | +184.4% | 0.13% | +127.6% |
| Q1 2020 | $735,000 | -9.0% | 50,625 | +26.8% | 0.06% | +28.9% |
| Q4 2019 | $808,000 | – | 39,922 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 111,608 | $2,470,000 | 3.15% |
| ACT CAPITAL MANAGEMENT, LLC | 180,000 | $3,983,000 | 2.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 167,889 | $3,715,000 | 1.92% |
| DG Capital Management, LLC | 402,200 | $8,901,000 | 1.81% |
| NEA Management Company, LLC | 5,172,683 | $114,471,000 | 1.36% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 801,100 | $17,728,000 | 0.99% |
| Altium Capital Management LP | 144,000 | $3,187,000 | 0.84% |
| HighMark Wealth Management LLC | 50,569 | $1,119,000 | 0.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 123,500 | $2,724,000 | 0.66% |
| SEVEN EIGHT CAPITAL, LP | 288,840 | $6,392,000 | 0.62% |